| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
77,400,000 |
| Market
Cap: |
687.31(M) |
| Last
Volume: |
924,004 |
Avg
Vol: |
1,535,793 |
| 52
Week Range: |
$4.32 - $9.91 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile SIGA Technologies is a commercial-stage pharmaceutical company focused on the health security markets. Co.'s primary product, TPOXX®, is a U.S. Food & Drug Administration-approved oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hruby Dennis E |
VP & Chief Scientific Officer |
• – – |
2015-06-05 |
4 |
S |
$1.60 |
$51,375 |
D/D |
(32,000) |
47,124 |
|
- |
|
| Luckshire Daniel J |
Executive VP & CFO |
• – – |
2015-06-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,583 |
53,102 |
|
- |
|
| Haynes William J Ii |
Executive VP & General Counsel |
• – – |
2015-06-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
26,437 |
|
- |
|
| Hruby Dennis E |
VP & Chief Scientific Officer |
• – – |
2015-06-04 |
4 |
S |
$1.61 |
$8,050 |
D/D |
(5,000) |
79,124 |
|
- |
|
| Rose Eric A Md |
Chief Executive Officer |
• • – |
2015-06-04 |
4 |
S |
$1.64 |
$20,336 |
D/D |
(12,400) |
447,897 |
|
- |
|
| Hruby Dennis E |
VP & Chief Scientific Officer |
• – – |
2015-06-03 |
4 |
S |
$1.78 |
$5,340 |
D/D |
(3,000) |
84,124 |
|
- |
|
| Rose Eric A Md |
Chief Executive Officer |
• • – |
2015-06-03 |
4 |
S |
$1.69 |
$21,125 |
D/D |
(12,500) |
460,297 |
|
- |
|
| Rose Eric A Md |
Chief Executive Officer |
• • – |
2015-06-02 |
4 |
S |
$1.80 |
$180 |
D/D |
(100) |
472,797 |
|
- |
|
| Antal James |
Director |
– • – |
2015-05-28 |
4 |
OE |
$1.22 |
$12,200 |
D/D |
10,000 |
66,154 |
|
- |
|
| Kindler Jeffrey B |
Director |
– • – |
2015-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
30,000 |
|
- |
|
| Stern Andrew L |
Director |
– • – |
2015-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
47,150 |
|
- |
|
| Antal James |
Director |
– • – |
2015-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
56,154 |
|
- |
|
| Constance Thomas E |
Director |
– • – |
2015-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
200,000 |
|
- |
|
| Bayer Michael J |
Director |
– • – |
2015-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
45,000 |
|
- |
|
| Slovin Bruce |
Director |
– • – |
2015-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
110,000 |
|
- |
|
| Marshall Joseph W Iii |
Director |
– • – |
2015-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
60,000 |
|
- |
|
| Savas Paul G |
Director |
– • – |
2015-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
106,840 |
|
- |
|
| Macandrews & Forbes Holdings Inc |
Director |
– • • |
2014-11-07 |
4 |
B |
$1.52 |
$196,913 |
I/I |
129,727 |
13,509,722 |
2.25 |
- |
|
| Macandrews & Forbes Holdings Inc |
Director |
– • • |
2014-11-06 |
4 |
B |
$1.46 |
$102,207 |
I/I |
70,000 |
13,379,995 |
2.25 |
- |
|
| Bayer Michael J |
|
• • – |
2014-10-16 |
4 |
S |
$1.49 |
$20,800 |
D/D |
(13,960) |
119,744 |
|
- |
|
| Slovin Bruce |
Director |
– • – |
2014-09-26 |
4 |
S |
$1.35 |
$33,750 |
D/D |
(25,000) |
95,000 |
|
- |
|
| Macandrews & Forbes Holdings Inc |
Director |
– • • |
2014-09-24 |
4 |
B |
$1.36 |
$71,914 |
I/I |
52,999 |
13,309,995 |
2.25 |
- |
|
| Macandrews & Forbes Holdings Inc |
Director |
– • • |
2014-09-23 |
4 |
B |
$1.33 |
$200,829 |
I/I |
151,158 |
13,256,996 |
2.25 |
- |
|
| Slovin Bruce |
Director |
– • – |
2014-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
120,000 |
|
- |
|
| Constance Thomas E |
Director |
– • – |
2014-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
185,000 |
|
- |
|
355 Records found
|
|
Page 8 of 15 |
|
|
0.07 (0.79%) 
